This text is a result of machine translation.
Estonian Prime Minister: NATO's defense strategy will cause Estonia to be "erased from the earth"
Fosun Pharmaceutical: the new tablet production line of the holding subsidiary passed the GMP compliance inspection
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Xuelang environment: affected by the epidemic situation, the subsidiary temporarily stopped production and resumed production
Harbin housing and Urban Rural Development Bureau organized and held a working meeting on handling the risk of overdue delivery and uncompleted tail of Evergrande real estate project
Angel yeast: Binzhou company plans to expand the green manufacturing project of 6000 tons of yeast extract
Fosun Pharmaceutical: the holding subsidiary started the phase II clinical study on the treatment of fs-1502 for non-small cell lung cancer
On May 11, Ping An of China spent 299 million yuan to buy back 6.6972 million a shares
Jiangsu Province has issued the outline of building a strong province with intellectual property rights, and will be fully built into a strong province with intellectual property rights in 2035
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Tesla unveiled a new giant 360mwh Megapack energy storage project
In the first quarter, the social security fund added 4 shares and increased its holdings of 10 shares
Nord shares: the net profit in 2021 increased by 7422% year-on-year, and the proposed 10 dividend is 0.6 yuan
Chengda biology: transfer relevant assets of Benxi human vaccine base to a wholly-owned subsidiary
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
Jiuyuan Yinhai: the holding subsidiary has passed the CMMI5 evaluation and certification
Shenghe resources: it plans to acquire 19.9% equity of peak company
CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future
Yesterday 12:26 PM
Charging Infrastructure on Government Support: A Brighter Future?
Mar 16, 2023 06:03 PM
Robot Policies in Asia
Mar 10, 2023 10:51 AM
Overview of ten Industrial Robot Company in China
Mar 10, 2023 12:59 AM